OBIO Launches Pre-Capital Access Advisory Program (Pre-CAAP) – Builds on Successful Capital Access Advisory Program (CAAP™) Improving financing success of Ontario bioscience companies Toronto, Ontario, August 10, 2015 – Ontario Bioscience Innovation Organization (OBIO®) today announced the launch of the inaugural round of Pre-CAAP, a program in support of Ontario bioscience companies that aim to raise...

Toronto, Ontario, May 22, 2015 – Ontario Bioscience Innovation Organization (OBIO®) today announced they have received an investment of up to $3.894 million from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) for OBIO®’s Capital Access Advisory Program (CAAP™).

“It is tremendous to see this practical support for commercializing health sciences and for building our human health bioscience industry,” said Gail Garland, President and CEO, OBIO®. “We are deeply grateful for this opportunity to expand our programming and help even more growing companies.”